HALOZYME THERAPEUTICS INC shareholders Q2 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
CWM, LLC 1,110$400.00%
M&R CAPITAL MANAGEMENT INC 32$1,1540.00%
Baker Avenue Asset Management, LP 7$2520.00%
Disciplined Investments, LLC 16$5770.00%
Cornerstone Planning Group LLC 26$9380.00%
FARMERS & MERCHANTS INVESTMENTS INC 57$2,0560.00%
Twin Tree Management, LP 1,639$59,1190.00%
Clearstead Advisors, LLC 78$2,8140.00%
AdvisorNet Financial, Inc 16$5770.00%
NewEdge Advisors, LLC 161$5,8080.00%
Rosenberg Matthew Hamilton 1$360.00%
Farther Finance Advisors, LLC 30$1,0820.00%
SJS Investment Consulting Inc. 20$7220.00%
Glassman Wealth Services 68$2,4530.00%
Allworth Financial LP 1,119$40,3630.00%
NewSquare Capital LLC 35$1,2620.00%
CENTRAL TRUST Co 300$10,8210.00%
D. E. Shaw & Co., Inc. 11,200$403,9840.00%
IFP Advisors, Inc 46$1,2580.00%
TRUST CO OF VERMONT 200$7,2140.00%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.